BlackRock Amends PacBio Stake, Signals Passive Investment Update

TL;DR

**BlackRock updated its passive stake in PACB as of year-end 2023.**

AI Summary

BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, indicating its ownership of Common Stock in PACIFIC BIOSCIENCES OF CALIFORNIA, INC. as of December 31, 2023. This amendment, number 10, updates previous disclosures regarding BlackRock's passive investment in the company. This matters to investors because BlackRock is a major institutional investor, and changes in its reported holdings can signal shifts in its investment strategy or outlook on Pacific Biosciences, potentially influencing other investors' perceptions of the stock.

Why It Matters

This filing shows BlackRock's updated, passive ownership in Pacific Biosciences, which can influence market sentiment and other institutional investors' decisions.

Risk Assessment

Risk Level: low — This is a routine amendment by a large institutional investor, indicating passive ownership, which typically carries low risk.

Analyst Insight

Investors should note BlackRock's continued, passive stake in Pacific Biosciences, but this filing alone doesn't suggest an immediate buy or sell action. It's a routine update from a major holder.

Key Players & Entities

• BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
• PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (company) — the issuer whose securities are being reported
• December 31, 2023 (date) — the date of the event requiring the filing
• January 24, 2024 (date) — the filing date of the SC 13G/A
• Amendment No: 10 (number) — the specific amendment number to the Schedule 13G

FAQ

From the Filing

0001086364-24-002668.txt : 20240124 0001086364-24-002668.hdr.sgml : 20240124 20240124172352 ACCESSION NUMBER: 0001086364-24-002668 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-85738 FILM NUMBER: 24557748 BUSINESS ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G/A 1 us69404d1081_012424.txt us69404d1081_012424.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10) PACIFIC BIOSCIENCES OF CALIFORNIA, INC. -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 69404D108 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 69404D108 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 23456946 (6) Shared voting power 0 (7) Sole dispositive power 24642666 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 24642666 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 9.2% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Item 1(b) Address of issuer's principal executive offices: --------------------------------------------------------